Vertex pharma establishes wholesale acquisition cost for trikafta of $311,503 on an annual basis

Vertex pharmaceuticals - established wholesale acquisition cost for trikafta in united states of $311,503 on an annual basis ($23,896 per 28-day pack).vertex pharmaceuticals - increasing guidance for full-year 2019 cf net product revenues to $3.70 billion - $3.75 billion.

VRTX Ratings Summary

VRTX Quant Ranking